OCS.
company based in Latvia
- Reports this week
- 1
- Active events
- 2
- Connections
- 54
What's happening
Active this week
Earlier this month
One to three months ago
-
CS overreach is impacting the operational independence of OCS in Kenya.Some support1 report
-
OCS is now a revenue segment of ADI.Some support1 report
-
OCS and North Sails participated in the XOD regatta on August 2, 2026.Some support2 reports
-
OCS is acquiring Mitie Group plc through a Scheme of Arrangement.Well supported7 reports1 development inside
-
OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.Some support1 report
-
A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.Some support1 report
-
OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.Some support2 reports
Gone quiet
No new reports in 90+ days-
An investigation into OCS is underway, focusing on market integrity issues in New York City.Some support2 reports
-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.Some support2 reports1 development inside
-
Nathan Miller assists in Oculis securities investigation.Some support1 report
-
OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.Some support1 report
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
BlackRock began managing funds for Oculis' loan facility.Some support1 report
-
OCS appointed Snehal Shah as President of R&D on August 12, 2025.Some support1 report
-
OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around OCS this week
News at the entities that move OCS most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves OCS
-
European Medicines Agency StructuralBoth the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Moves OCS
-
Kenya StructuralAllegations of border issues involving election materials are reported between Uganda and Kenya.Moves OCS
-
London Stock Exchange StructuralQinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.Moves OCS
-
Nvidia OperationalNvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.Moves OCS
-
BlackRock TransactionalHeemskerk heads the Climate Change Centre at ECB, and a BlackRock executive issues a similar climate warning.Moves OCS
Connections
The 25 strongest of 54, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
ADI Structural
OCS functions as a defined revenue segment within the corporate structure of ADI.
-
Transmedics Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
Nasdaq Structural
OCS is formally listed on the Nasdaq stock exchange, establishing a structural dependency on the platform.
-
European Medicines Agency Structural
OCS is undergoing the formal regulatory review process with the European Medicines Agency, culminating in the PRIME designation for its product.
-
FDA Structural
OCS relies on the FDA for product approval, clearance, and regulatory designations like Breakthrough Therapy.
-
Kenya Structural
Kenya's regulatory actions (CS overreach) impact the operational independence of OCS.
-
London Stock Exchange Structural
OCS relies on the London Stock Exchange as the operational venue for executing its corporate acquisitions.
-
SUMMIT Transactional
OCS is providing financial sponsorship for clinical trials being held at the Summit 2026 infrastructure event.
Show all 25 connections
-
Nvidia Operational
OCS is anticipated to derive new revenue streams from its operational relationship with Nvidia's market.
-
Nathan Miller Transactional
Nathan Miller is engaged to provide expert assistance regarding OCS's securities investigation.
-
Galatea Mentioned together
The evidence suggests OCS is mentioned in the context of market leadership that impacts competitors.
-
BlackRock Transactional
BlackRock provides loan facility management and financing to OCS.
-
Lumentum Holdings Transactional
Lumentum benefits commercially from OCS's pricing structure.
-
New York City Shared context
OCS operates within the market and regulatory context of New York City, which is currently under investigation regarding market integrity issues.
-
Securities and Exchange Commission Structural
OCS is subject to formal regulatory oversight by the SEC, requiring the filing of official reports.
-
Switzerland Shared context
OCS is headquartered and operates in Switzerland.
-
Nevada Shared context
The single piece of evidence places an event in Nevada, but provides no direct coupling or interaction between Nevada and OCS.
-
MIaMI Shared context
OCS management is scheduled to attend a conference in Miami.
-
Iceland Shared context
OCS maintains operational presence and holds investor meetings within Iceland.
-
Lorain County Shared context
OCS operates within the jurisdiction of Lorain County, providing support services to its residents.
-
Y. Chen Mentioned together
The evidence is insufficient to establish a relationship between OCS and Y. Chen.
-
Google Mentioned together
No direct relationship between OCS and Google is observed in the provided evidence.
-
North Sails Shared context
Both companies shared a context by participating in the XOD regatta.
-
Microsoft Mentioned together
No evidence was found linking OCS and Microsoft in the provided timeline.
-
William Ruto Mentioned together
The provided evidence does not describe a relationship between OCS and William Ruto.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
5 events- OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.
- OCS is listed on the Nasdaq stock exchange and its financial reporting is tied to the US market.
- CS overreach is impacting the operational independence of OCS in Kenya.
- OCS is now a revenue segment of ADI.
- OCS and North Sails participated in the XOD regatta on August 2, 2026.
July 2026
4 events- OCS is acquiring Mitie Group plc through a Scheme of Arrangement.
- OCS recommended a cash acquisition of Mitie shares, with Chetan Patel holding shares requiring irrevocable undertakings.
- A £5.1bn bid for easyJet was announced, while OCS acquired Mitie Group plc shares at a premium.
- OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.
Show 1 earlier month
June 2026
11 events- Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.
- An investigation into OCS is underway, focusing on market integrity issues in New York City.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Oculis Holding AG secured an upsized loan facility from BlackRock and issued results from Zug, Switzerland.
- Nathan Miller assists in Oculis securities investigation.
- OCS appointed Sebastian Wolf as Chief Medical Advisor for Ophthalmology in Zug on August 25, 2025.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- BlackRock began managing funds for Oculis' loan facility.
- OCS appointed Snehal Shah as President of R&D on August 12, 2025.
- OCS collaborated with EURETINA on an award, recognizing Prithvi Ramtohul with the Tadayoni Award, which was presented by Anat Loewenstein.